GMED Share Price

Open 33.61 Change Price %
High 34.00 1 Day 0.39 1.16
Low 33.57 1 Week 1.00 3.03
Close 33.95 1 Month 3.36 10.98
Volume 606435 1 Year 10.10 42.35
52 Week High 34.00
52 Week Low 19.25
GMED Important Levels
Resistance 2 34.35
Resistance 1 34.18
Pivot 33.84
Support 1 33.72
Support 2 33.55
NYSE USA Most Active Stocks
AMD 14.17 -1.46%
AMD 14.17 -1.46%
AMD 14.17 -1.46%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
BAC 22.82 -0.48%
BAC 22.82 -0.48%
BAC 22.82 -0.48%
SE 40.68 -0.78%
More..
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
GLF 0.34 25.93%
GLF 0.34 25.93%
FNP 35.24 12.02%
FNP 35.24 12.02%
WG 2.38 11.74%
WG 2.38 11.74%
TOO 2.15 10.26%
DAC 1.65 10.00%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Globus Medical, Inc. (NYSE: GMED)

GMED Technical Analysis 5
As on 23rd Jun 2017 GMED Share Price closed @ 33.95 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 26.15 & Strong Buy for SHORT-TERM with Stoploss of 31.33 we also expect STOCK to react on Following IMPORTANT LEVELS.
GMED Target for June
1st Target up-side 32.85
2nd Target up-side 34.33
3rd Target up-side 35.8
1st Target down-side 28.65
2nd Target down-side 27.17
3rd Target down-side 25.7
GMED Other Details
Segment EQ
Market Capital 1372512512.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.globusmedical.com
GMED Address
GMED
2560 General Armistead Avenue
Audubon, PA 19403
United States
Phone: 610-930-1800
Fax: 610-930-2042
GMED Latest News
Interactive Technical Analysis Chart Globus Medical, Inc. ( GMED NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Globus Medical, Inc.
GMED Business Profile
Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. It offers approximately 120 products that address an array of spinal pathologies, anatomies, and surgical approaches. The company’s fusion products are used in cervical, thoracolumbar, sacral, and interbody/corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions. Its disruptive technology products provide material improvements to fusion procedures, such as minimally invasive surgical techniques, as well as new treatment alternatives, which include motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous process spacer products, and advanced biomaterials technologies; and interventional pain management solutions, including treatments for vertebral compression fractures. The company has received pre-market approval for SECURE-C Cervical Artificial Disc; and conducting other clinical trials for ACADIA Facet Replacement System, a motion preserving anatomic reconstruction of the facet joint intended for the treatment of spinal stenosis, as well as TRIUMPH Lumbar Disc, a motion preserving disc replacement inserted obliquely into the disc space from a posterolateral approach to address posterior spinal pathology and maintain important anterior anatomical structures. Globus Medical, Inc. sells its implants and related disposables primarily to hospitals. The company markets and sells its products through sales representatives and independent distributors in the United States and internationally. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania.